TY - JOUR
T1 - Platelet glycoprotein IIb/IIIa receptor blockade
T2 - Lessening the risk of coronary interventions
AU - Pitts, W. R.
AU - Lange, R. A.
PY - 1999
Y1 - 1999
N2 - For the patient undergoing percutaneous coronary intervention, the administration of a platelet glycoprotein IIb/IIIa receptor blocker reduces the incidence of a periprocedural nonfatal myocardial infarction and the need for unplanned emergency stenting. In the diabetic patient undergoing intracoronary stenting, the use of a platelet glycoprotein IIb/IIIa receptor blocker appears to decrease the need for subsequent target vessel revascularization. There is considerable evidence in support of the use of glycoprotein IIb/IIIa receptor inhibitors in all categories of patients - 'high-risk' patients, 'low-risk' patients, and those undergoing primary angioplasty for acute myocardial infarction - and for the full armamentarium of percutaneous procedures (angioplasty, directional atherectomy, rotational atherectomy, and intracoronary stenting).
AB - For the patient undergoing percutaneous coronary intervention, the administration of a platelet glycoprotein IIb/IIIa receptor blocker reduces the incidence of a periprocedural nonfatal myocardial infarction and the need for unplanned emergency stenting. In the diabetic patient undergoing intracoronary stenting, the use of a platelet glycoprotein IIb/IIIa receptor blocker appears to decrease the need for subsequent target vessel revascularization. There is considerable evidence in support of the use of glycoprotein IIb/IIIa receptor inhibitors in all categories of patients - 'high-risk' patients, 'low-risk' patients, and those undergoing primary angioplasty for acute myocardial infarction - and for the full armamentarium of percutaneous procedures (angioplasty, directional atherectomy, rotational atherectomy, and intracoronary stenting).
KW - Glycoprotein IIb/IIIa
KW - PTCA
KW - Platelets
KW - Stent
UR - http://www.scopus.com/inward/record.url?scp=0033367060&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033367060&partnerID=8YFLogxK
U2 - 10.1055/s-0037-1615572
DO - 10.1055/s-0037-1615572
M3 - Article
C2 - 10695505
AN - SCOPUS:0033367060
VL - 82
SP - 136
EP - 138
JO - Thrombosis and Haemostasis
JF - Thrombosis and Haemostasis
SN - 0340-6245
IS - SUPPL. 1
ER -